Joel Greenblatt acquired 2.68k Novartis AG shares worth $385k. That's 0.00% of their equity portfolio (1516th largest holding). Joel Greenblatt started to build up the position in Novartis AG in Q2 2025 and continued to invest until Q4 2025. Since then they sold 72 shares. The stake costed the investor $318k, netting the investor a gain of 21% so far.